<DOC>
	<DOCNO>NCT00298506</DOCNO>
	<brief_summary>This open , prospective study ass efficacy safety Tacrolimus ( FK506 ) combine MMF treatment class III , IV , V + IV V + III lupus nephritis .</brief_summary>
	<brief_title>Study Assess Efficacy Safety FK506 Combined With Mycophenolate Mofetil ( MMF ) Lupus Nephritis ( III/IV/V )</brief_title>
	<detailed_description>1 . To assess efficacy FK506 combine MMF v intravenous CTX pulse treatment class Ⅲ , Ⅳ , Ⅴ + Ⅳ Ⅴ + Ⅲ LN . 2 . To investigate safety tolerability FK506 combine MMF v intravenous CTX pulse treatment class Ⅲ , Ⅳ , Ⅴ + Ⅳ Ⅴ + Ⅲ LN . 3 . To explore dose FK506 combine MMF effective range blood concentration .</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1 . Female patient diagnosis systemic lupus erythematosus ( SLE ) accord criterion American Rheumatic Association , 1982 , age 1250 year , score SLEDAI ( Disease Active Index ) 12 ( include class V LN ) . 2 . Patients diagnose accord ISN/RPS 2003 classification criterion : class Ⅲ , Ⅳ , Ⅳ + Ⅴ , Ⅲ + Ⅴ LN renal biopsy within 3 month , CI〈 4，Scr〈 3 mg/dl . 3 . Patients proteinuria ≥ 1.5 g/24h , active urine sediment . 4 . Patients sign write informed consent form ( patient less 18 year old parents/legal representative ' signature ) , give consent follow study procedure followups . 1 . Patients receive treatment cytotoxic drug cyclophosphamide ( CTX ) , cyclosporine A 1 week within three month . 2 . Patients serum creatinine ≥ 3 mg/dl（265 μmol/L ) . 3 . Patients severe infection central nervous system symptom . 4 . Patients impaired liver function , ALT/GPT AST/GOT twice normal upper limit active hepatitis . 5 . Patients abnormal blood glucose , fast blood glucose &gt; 6.2 mmol/L post meal blood glucose &gt; 11.2 mmol/L . 6 . Patients pregnant lactate . 7 . Patients know allergic macrolide .</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Tacrolimus</keyword>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Lupus nephritis</keyword>
	<keyword>Treatment</keyword>
</DOC>